Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

IntroductionHaploidentical allogeneic hematopoietic cell transplantation (haplo-HCT) using post-transplant cyclophosphamide (PTCY) has become a standard approach for patients lacking HLA-matched donors. While effective in reducing graft-versus-host disease (GVHD), concerns about PTCY-associated card...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Filipe R. Pinto, Enric Cascos, Estefanía Pérez-López, Mónica Baile-González, Carlos Martín Rodríguez, María Jesús Pascual Cascón, Marta Luque, Albert Esquirol, Carmen Martín Calvo, Felipe Peña-Muñóz, Inmaculada Heras Fernando, Itziar Oiartzabal Ormtegi, Adolfo Jesús Sáez Marín, Sara Fernández-Luis, Juan José Domínguez-García, Sara Villar Fernández, José Luis López Lorenzo, Miguel Fernández de Sanmamed Girón, Leslie González Pinedo, Lucía García, Ana Pilar González-Rodriguez, Tamara Torrado, Silvia Filaferro, Pascual Basalobre, Alberto López-García, Guillermo Ortí, Manuel Jurado Chacón, María Queralt Salas
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	Haplo-HCT PTCY early cardiac events cardiovascular toxicity AML GVHD prophylaxis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1571678/full